SCHEMBL6707652

SCHEMBL6707652

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)c4csc(SCc5ccccc5)n4)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.34
KDM4E B2RXH2 5/20 0.34
MAPT P10636 5/20 0.34
ALDH1A1 P00352 5/20 0.34
HPGD P15428 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ALPL P05186 1/20 0.33
LMNA P02545 1/20 0.33
ABL1 P00519 2/20 0.33
SRC P12931 2/20 0.33
POLB P06746 1/20 0.32
GFER P55789 1/20 0.32
CTSB P07858 1/20 0.32
GAA P10253 3/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
PPARG P37231 1/20 0.32
PPP1CA P62136 1/20 0.32
HKDC1 Q2TB90 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711805 0.90 ABL1 (0.39) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL6711795 0.89 ABL1 (0.34) PTPN1KDM4EMAPTALDH1A1HPGD
SCHEMBL6713204 0.87 ACMSD (0.36) PTPN1KDM4EMAPTALDH1A1HPGD
SCHEMBL6833982 0.85 ALB (0.37) PTPN1POLBCTSB
SCHEMBL6711927 0.85 PARP14 (0.44) MAPTLMNAPOLBPARP14
SCHEMBL6710250 0.84 KMT2A (0.42) KMT2AMEN1RXFP1PARP14NPC1
SCHEMBL6714403 0.83 PARP14 (0.37) KDM4EALDH1A1HPGDPOLBNCOR2
SCHEMBL6710181 0.83 L3MBTL1 (0.43) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL6916001 0.83 PARP14 (0.42) LMNAPOLBKMT2AMEN1NCOR2
SCHEMBL6709018 0.82 PKM (0.35) MAPTLMNAPOLBRXFP1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PTPN1 3364/4885KDM4E 1582/4885MAPT 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.